In addition, somatic mutations in the telomerase reverse transcriptase (TERT) promoter that enhance TERT expression were shown to be among the earliest and most prevalent neoplastic event in HCV-related HCC (HCV-HCC) [79]. Here, TERT is linked to hepatocellular carcinoma.